About MycoWorks
MycoWorks is a private company based in Emeryville, California. It has reported $220,608,635 raised in four offerings on Form D since November 2021. Its chief executive is Matthew Scullin.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 3, 2022 | Jun 16, 2023 | $37,050,853of $63.1M target | 11 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Jan 6, 2022 | Apr 4, 2022 | $124,999,960fully sold | 17 | $7.3M | EquityRule 506(b) | Form D ↗ |
| Oct 14, 2020 | Nov 16, 2021 | $44,781,773fully sold | 32 | $1.3M | Equity, DebtRule 506(b) | Form D ↗ |
| May 8, 2019 | Nov 16, 2021 | $13,776,049fully sold | 31 | $444K | Equity, DebtRule 506(b) | Form D ↗ |
| Total, four offerings | $220,608,635 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MycoWorks's Form D filed Jun 16, 2023.
Earlier filings also listed Tjerk Ruiter (director, last listed Apr 2022), Anders Spohr (director, last listed Apr 2022), Thomas Grotkjaer (director, last listed Nov 2021), Philip Ross (director, last listed Nov 2021), Michael Lindheim (chief operating officer, last listed Nov 2021) and Chris Hill (director, last listed Nov 2021).